Tribunal Upholds 5% Duty on Imported Homeopathic Medicines

The Tribunal ruled that imported homeopathic medicines are subject to Additional Customs Duty (ACD) at 5%, aligning with the excise duty on similar Indian goods to ensure fair competition. It held that the Commissioner (Appeals) exceeded jurisdiction by addressing the duty's constitutionality. The Tribunal emphasized that statutory authorities should not delve into constitutional matters. It was established that imported goods availed input tax credit in the exporting country, justifying the 5% ACD. The decision overturned the reduced 1% duty, emphasizing the need for competitive parity. The Revenue's appeals were allowed, reinstating the 5% ACD imposition.

---

---

Issues Involved:

1. Whether the imported homeopathic medicines are liable to Additional Customs Duty (ACD) at 5% or 1%/2% as per Notification No.1/2011-CE dated 01.03.2011.
2. Whether the Commissioner (Appeals) exceeded his jurisdiction by deciding on the constitutionality of the duty imposed.
3. Whether the imported goods availed CENVAT credit or input tax credit in the exporting country, thereby justifying the ACD at 5%.

Issue-wise Detailed Analysis:

1. Liability of Imported Homeopathic Medicines to Additional Customs Duty (ACD):

The primary issue is whether the imported homeopathic medicines should be subjected to ACD at 5% or at a reduced rate of 1%/2% as per Notification No.1/2011-CE dated 01.03.2011. The Tribunal examined Section 3(1) of the Customs Tariff Act, 1975, which mandates that imported goods should bear ACD equivalent to the excise duty on similar goods manufactured in India. The Tribunal noted that the homeopathic medicines manufactured in India were subject to excise duty at 5%, with a reduced rate of 1% if no CENVAT credit was availed. It was concluded that the imported goods must bear ACD at 5% to ensure a level playing field and fair competition, aligning with the WTO agreement that mandates remission of input duties on exported goods.

2. Jurisdiction of Commissioner (Appeals):

The Revenue contended that the Commissioner (Appeals) overstepped his jurisdiction by addressing the constitutionality of the duty imposed, a power reserved for constitutional authorities. The Tribunal agreed, stating that the Commissioner (Appeals) should have confined his decision within the statutory framework without converting the appeal into a writ petition. The Tribunal emphasized that a statutory authority should not usurp the powers of a constitutional authority.

3. Availment of CENVAT Credit or Input Tax Credit:

The Tribunal assessed whether the imported goods availed CENVAT credit in the exporting country, which would justify the imposition of ACD at 5%. It was established that under WTO agreements, member countries, including Germany (the exporting country in this case), provide input tax credit or remission on exported goods. Consequently, the imported homeopathic medicines, being duty-free in the exporting country, should bear ACD at 5% to counterbalance the excise duty levied on similar goods manufactured in India. The Tribunal referenced the case of Hyderabad Industries Ltd. and other precedents to affirm that the levy of ACD is justified to maintain competitive parity.

Conclusion:

The Tribunal concluded that the imported homeopathic medicines are liable to ACD at 5%, overturning the Commissioner (Appeals)' decision which had reduced the duty to 1%. The Tribunal underscored the necessity of maintaining a level playing field and fair trade practices, adhering to both domestic laws and international agreements. The appeals by the Revenue were allowed, reinstating the adjudication orders that imposed ACD at 5%.

(Pronounced in the open Court on 23.09.2014)

---